Hansen Ree, A. et al. 2020. Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer – the MetAction study. Acta Oncologica. 59, 7 (Jul. 2020), 733–740. DOI:https://doi.org/10.1080/0284186X.2020.1742377.